Patents by Inventor John Martin Mariadason

John Martin Mariadason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers for selecting personalized therapies for the treatment of cancer
    Patent number: 9028831
    Abstract: The invention relates to the identification of aprataxin (APTX) expression levels as a marker for the response to topoisomerase I inhibitor-based therapies in patients with cancer and, more particularly, colon cancer. The invention also relates to methods for treating patients with cancer who have low APTX expression levels by means of administering a topoisomerase I inhibitor to said patients.
    Type: Grant
    Filed: September 1, 2010
    Date of Patent: May 12, 2015
    Assignee: Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privado
    Inventors: Diego Arango Del Corro, Simó Schwartz Navarro, John Martin Mariadason
  • MARKERS FOR SELECTING PERSONALIZED THERAPIES FOR THE TREATMENT OF CANCER
    Publication number: 20120231020
    Abstract: The invention relates to the identification of aprataxin (APTX) expression levels as a marker for the response to topoisomerase I inhibitor-based therapies in patients with cancer and, more particularly, colon cancer. The invention also relates to methods for treating patients with cancer who have low APTX expression levels by means of administering a topoisomerase I inhibitor to said patients.
    Type: Application
    Filed: September 1, 2010
    Publication date: September 13, 2012
    Applicant: Fundacio Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada
    Inventors: Diego Arango Del Corro, Simó Schwartz Navarro, John Martin Mariadason